Higher Education Commission should start publishing some journals to learn the problems faced in Scientific Publishing

ISLAMABAD: Higher Education Commission of Pakistan which perhaps does not have many people with medical background is neither fully aware of the problems faced in scientific publishing nor those at the helm of affairs are interested to learn.

Read more...

World Psychiatric Association’s Action Plan for 2020-2023

Psychiatry is currently facing several challenges, and although our profession may be seen as being under threat, there are many opportunities that can help us consolidate psychiatry as an inspiring branch of medicine.

Read more...

HCPs should examine advantages of social distancing, quarantine effects, hand hygiene

ISLAMABAD: Only a very negligible or a few trials currently going on in Covid19 research has taken up the topics of examining social distancing, quarantine effects or hand hygiene. According to reports over one thousand clinical trials were registered on ClinicalTrials.gov

Read more...

COVID-19 has started affecting mental health of people all over the world-Prof. Haroon Ahmad

KARACHI: Pakistan Psychiatric Society (PPS) and Department of Psychiatry and Behavioural Sciences, Jinnah Postgraduate Medical Center (JPMC) Karachi at Najmuddin Auditorium to celebrate World Mental Health Day. 

Read more...

COVID-19 Pandemic & False News Hoaxes

Seven months into the worst Pandemic of a lifetime the virus continuous to spread alongside medical myths and health hoaxes. These have made doctor’s job harder. False news is not a new phenomenon but it has been amplified by the social media.

Read more...

Trends in Industry Payments to Physicians in the United States from 2014 to 2018

Background and Objective: Open Payments, a federal transparency program reporting industry-physician financial relationships since 2013, was established out of concern for undue industry influence on health care decision-making and costs.

Read more...

Vaccine for Covid19 being considered great breakthrough

WASHINGTON: Announcement by one of the teams developing vaccine for COVID19 claiming 90% effectiveness against the illness is being considered as a great break through. The business has also responded in a very positive way but it is too early to come to any conclusions. 

Read more...

Superiority of Cilostazol among antiplatelet FDA-approved drugs against COVID 19 Mpro and spike protein: Drug repurposing approach

Abstract: Coronavirus disease 2019 (COVID 19) was first identified in Wuhan, China near the end of 2019. To date, COVID-19 had spread to almost 235 countries and territories due to its highly infectious nature. Moreover, there is no vaccine or Food and Drug Administration (FDA)-approved drug.

Read more...

Supporting Immunotherapy Innovations is vital even when Clinical Benefit is not immediately clear

DOHA (QATAR): Clinical trials are revealing crucial roles for immunotherapies and new options in treating previously incurable and life-limiting diseases, according to a WISH 2020 research report Realizing the Promise of Immunotherapy:

Read more...

Landmark TB Trial Identifies Shorter-Course Treatment Regimen

Results from an international, randomized, controlled clinical trial indicate that a four-month daily treatment regimen containing high-dose, or optimized Rifapentine with Moxifloxacin is as safe and effective as the existing standard six-month daily regimen at curing drug-susceptible tuberculosis (TB) disease.

Read more...

© Professional Medical Publications. All rights reserved.